Giant cell tumor of bone: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 14: | Line 14: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Giant cell tumor of the bone accounts for 4-5% of primary bone tumors and 18.2% of benign bone tumors <ref name="pmid12579271">{{cite journal |author=Gamberi G, Serra M, Ragazzini P, Magagnoli G, Pazzaglia L, Ponticelli F, Ferrari C, Zanasi M, Bertoni F, Picci P, Benassi MS |title=Identification of markers of possible prognostic value in 57 giant cell tumors of bone |journal=[[Oncology Reports]] |volume=10 |issue=2 |pages=351–6 |year=2003 |pmid=12579271 |doi= |url=http://www.spandidos-publications.com/or/10/2/351 |accessdate=2012-01-18}}</ref>. | |||
==Risk Factors== | ==Risk Factors== | ||
Revision as of 20:03, 9 March 2016
For patient information, click here Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Osteoclastoma; giant cell myeloma; giant cell tumor
Overview
Historical Perspective
Pathophysiology
Causes
Epidemiology and Demographics
Giant cell tumor of the bone accounts for 4-5% of primary bone tumors and 18.2% of benign bone tumors [1].
Risk Factors
Screening
Differentiating Giant cell tumor of bone from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Treatment
Medical Therapy
Surgery
References
- ↑ Gamberi G, Serra M, Ragazzini P, Magagnoli G, Pazzaglia L, Ponticelli F, Ferrari C, Zanasi M, Bertoni F, Picci P, Benassi MS (2003). "Identification of markers of possible prognostic value in 57 giant cell tumors of bone". Oncology Reports. 10 (2): 351–6. PMID 12579271. Retrieved 2012-01-18.